Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Compare rebalancing frequency between index funds and target-date funds and what that means for risk, fees, and long-term performance. A quick look at when to expect adjustments.
28,361 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Tech-focused investors watched TeraWulf surge after a major AI data-center lease deal, signaling potential recurring ...
California prices could soon surge past seven dollars per gallon as crude costs climb and refining limits bite, with ...
Rising retiree incomes are pushing more Social Security benefits into taxation. Here’s how the rules work, who is aff...
Galaxy Digital lowers its odds on the CLARITY Act, putting clarity chances passage this year at 60% as lawmakers rush...
A pension election could dramatically reshape survivor finances. A high-wealth household faces a stark tradeoff betwe...
A California jury confronts a high-stakes question: can the way social apps are built cause harm to young users? The ...
Alphabet is quietly pivoting its AI strategy toward a new growth engine something. This shift could tilt Google Cloud...
Tech stocks wobbled Friday as yields spiked, triggering a risk-off pullback. This piece lays out where to position wh...
A well-known trading app moving deeper into crypto and tokenized assets could reshape where traders park capital. Thi...
Garmin, Synaptics, and QuantumScape blend device hardware, AI-ready tech, and next-gen batteries in a low-profile tri...
A Kentucky GOP primary produced a win for a Trump-backed challenger, marking a new chapter in Trump’s hold on the par...